CLINICAL TRIALS PROFILE FOR NEPAFENAC
✉ Email this page to a colleague
All Clinical Trials for NEPAFENAC
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00330798 ↗ | A Comparison of Topical Nepafenac to Placebo in Corneal Epithelial Healing Times and Postoperative Pain Relief | Completed | Matthew Caldwell | Phase 4 | 2006-02-01 | The purpose of this study is to compare healing times and subjective pain level responses of nepafenac to placebo after photo refractive keratomileusis (PRK) surgery. |
NCT00330798 ↗ | A Comparison of Topical Nepafenac to Placebo in Corneal Epithelial Healing Times and Postoperative Pain Relief | Completed | Alcon Research | Phase 4 | 2006-02-01 | The purpose of this study is to compare healing times and subjective pain level responses of nepafenac to placebo after photo refractive keratomileusis (PRK) surgery. |
NCT00333255 ↗ | Nepafenac Opthalmic Suspension 0.1% Compared to Acular LS for Treatment of Inflammation After Cataract Surgery | Completed | Alcon Research | Phase 3 | 2005-09-01 | The purpose of this study is to compare the effectiveness of Nepafenac Ophthalmic Suspension, 0.1% eye drops to Acular LS eye drops, used before and after cataract surgery, for treating inflammation in the eye. |
NCT00377546 ↗ | Comparison of Vitreous Levels of Acular LS 0.04%, Xibrom 0.09%, and Nevanac 0.1% | Completed | Innovative Medical | Phase 4 | 1969-12-31 | To compare the penetration of three different NSAIDs. |
NCT00405730 ↗ | Nepafenac 0.1% Eye Drops, Suspension Compared to Ketorolac Trometamol 0.5% Eye Drops, Solution and Placebo | Completed | Alcon Research | Phase 3 | 2005-11-01 | To evaluate the safety and efficacy of Nepafenac 1 mg/ml Eye Drops, Suspension, compared to Placebo and Ketorolac Trometamol 5 mg/ml Eye Drops, Solution for the prevention and treatment of ocular inflammation and ocular pain after cataract extraction with IOL implantation |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for NEPAFENAC
Condition Name
Clinical Trial Locations for NEPAFENAC
Trials by Country
Clinical Trial Progress for NEPAFENAC
Clinical Trial Phase
Clinical Trial Sponsors for NEPAFENAC
Sponsor Name